Obesity and insulin resistance are the hallmarks of abnormal glucose tolerance (Abnl-GT) in African Americans and African Caribbeans. In contrast, prevalence, phenotype and etiology of Abnl-GT in African-born blacks are unknown. Working with African-born blacks living in America, we determined (a) the prevalence of Abnl-GT, and (b) the etiology of Abnl-GT by BMI category (i.e., primary β-cell failure vs. insulin resistance). OGTT was performed in 461 African-born blacks (male: 66%; age: 39±10 (mean±SD), range: 20-65y; BMI: 27.6±4.5, range: 18.4-42.4 kg/m2). Abnl-GT was diagnosed by glycemia: 0h glucose≥100 or 2h glucose≥140 mg/dL. Insulin resistance was defined by the cutoff at the lowest quartile of the Matsuda Index for the population (≤2.97). Primary β-cell failure was diagnosed if Abnl-GT was present and Matsuda Index was >2.97. Obesity occurred in 27% (123/461). Abnl-GT occurred in 38% (173/461). By BMI category, Abnl-GT occurred in 35% (117/338) of the nonobese and 46% (56/123) of the obese. Overall, β-cell failure occurred in 61% (105/173) of participants with Abnl-GT (Figure). Yet, the odds of primary β-cell failure as the cause of Abnl-GT were 4 times higher in the nonobese than the obese (OR: 4.2; 95% CI: 2.2, 8.3). In short, the prevalence of Abnl-GT was high in both nonobese and obese African-born blacks. However, in nonobese Africans with Abnl-GT, primary β-cell failure was more common than insulin resistance.


A.F. Hobabagabo: None. T. Hormenu: None. E.M. Shoup: None. N.H. Osei-Tutu: None. C. DuBose: None. L. Mabundo: None. S.T. Chung: None. A.E. Sumner: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.